Dassault Systèmes and Medidata Solutions To Join Forces


Applied Clinical Trials

Dassault Systèmes and Medidata Solutions, Inc. have announced the signing of a definitive agreement for Dassault Systèmes to acquire Medidata. The transaction, representing an enterprise value of $5.8 billion, was unanimously approved by the Boards of Directors of both companies.

To learn more, click here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
Related Content
© 2024 MJH Life Sciences

All rights reserved.